BrightInsight Expands its Partnership with Google Cloud to Enhance the Patient Journey Through Generative AI
2024年5月7日 - 9:05PM
BrightInsight, Inc, the trusted partner and platform driving value
for top biopharma compliant digital health solutions, announced
today that it will deploy Google Cloud’s Gemini and MedLM
generative AI (gen AI) models on the Vertex AI platform to optimize
its research and development engine and enhance its Disease
Management Solution for patients and providers.
Across therapeutic areas, the patient journey presents many
challenges, including access and financial hurdles, progression
from first- to second-line therapies, complex treatment
administration, and tracking symptoms and effectiveness over time.
Companion apps are one way to help patients better manage their
diseases, and multimedia educational content is a key component,
such as educational articles about gene therapies or tutorial
videos for at-home self-injections.
BrightInsight has embedded a Google Gemini model-powered chatbot
within its Disease Management Solution to provide patients improved
access to approved content. For instance, instead of a patient
having to read through multiple care documents to answer a
question, BrightInsight delivers an answer right away by culling
through all of the clinically validated information available from
the biopharma company. The chatbot also serves as first-line
support to more quickly and more specifically answer questions from
patients around app usage.
BrightInsight is also using Gemini Code Assist to speed up and
make its internal research and development processes more efficient
in three ways: 1) more effectively develop and operate Google Cloud
components, 2) more efficiently troubleshoot, and 3) improve the
analytics and insights for BrightInsight customers. One of
BrightInsight’s unique value propositions is its ability to
generate dashboards with never-before-had, unique, real-world data
about therapy administration, patient app utilization, and more.
Google Cloud’s BigQuery data warehouse makes these dashboards and
data more powerful and actionable.
Lastly, BrightInsight is also leveraging Google Cloud’s MedLM to
summarize, interact with, and probe patient data from companion
apps. Making patient app data digestible, queryable and actionable
for clinicians provides tremendous value, including enabling more
impactful and data-driven conversations between patients and
providers. For instance, instead of having to pore over patient
medical records, care providers can quickly access missed
medication dosage or abnormal blood glucose readings from patient
data, and thereby have more focused follow-up conversations.
“We have invested a lot in building best-in-class technology and
hiring top engineering talent,” said Ashish Agrawal, chief
technology officer, BrightInsight. “Partnering with Google Cloud
and leveraging its AI technologies will enable BrightInsight to
supercharge its solutions to achieve our vision of transforming
patient outcomes through digital technologies.”
“Making it easier for patients to understand their health and
complex medical information is such an important change,” said Ryan
Terry, managing director, Healthcare and Life Sciences, Google
Cloud. “BrightInsight’s innovative use of Gemini models, MedLM, and
Vertex AI will accelerate this important transformation of the
patient journey.”
As BrightInsight continues to invest in gen AI-based solutions,
it will do so in a responsible way. BrightInsight has developed its
Platform and Disease Management Solution according to the highest
security, privacy, and compliance controls, achieving
certifications against global standards, and it will approach the
integration of AI with the same rigor and care. The features in
this press release are features that clients, and patients, can
opt-in to at the app level to suit their use case and patient care
journey.
Google Cloud’s customers retain control over their data. In
healthcare settings, access and use of patient data is protected
through the implementation of Google Cloud’s infrastructure and
data storage that support Health Insurance Portability and
Accountability Act (HIPAA) and General Data Protection Regulation
(GDPR) compliance, along with each customer’s security and privacy
controls.
About BrightInsight:BrightInsight provides the
leading global platform for biopharma and medtech regulated digital
health solutions. When speed matters, we help companies accelerate
time to market for regulated digital health offerings across
therapeutic areas, including apps, healthcare provider interfaces,
analytics dashboards, algorithms, medical devices, connected
combination products, diagnostics and Software as a Medical Device
(SaMD). BrightInsight replaces the need for lengthy and complex
‘build from scratch’ implementations by offering configurable
software solutions and a proven platform built on Google Cloud
under a Quality Management System to support global security,
privacy and regulatory requirements. When building digital health
products on the BrightInsight Platform, compliance is
future-proofed as intended use changes scale across
geographies.
For more information, visit BrightInsight’s website, Blog,
Twitter and LinkedIn pages.
Media Contacts:Jamie BurgessSVP of Marketing, BrightInsight(669)
268-2838jamie.burgess@brighinsight.com
Helen Shik Shik Communications (617)
510-4373 helen@shikcommunications.com
Copyright © 2024 BrightInsight, Inc. BrightInsight and the
BrightInsight logo are trademarks of BrightInsight, Inc. Other
trademarks are the trademarks of their owners.